Skip to content
Menu

Bernstein Maintains Outperform on Agilon Health, Raises Price Target to $138

Benzinga Newsdesk 14 hours ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Bernstein analyst Lance Wilkes maintains Agilon Health (NYSE:AGL) with a Outperform and raises the price target from $125 to $138.

Bernstein analyst Lance Wilkes maintains Agilon Health (NYSE:AGL) with a Outperform and raises the price target from $125 to $138.

Read at benzinga.com